Precision BioSciences, Inc. (DTIL)

Precision BioSciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	99.37	110.82	85.9	116.68	189.58	143.66
Short-Term Investments	1.81	4.76	0.41	-	-	-
Cash & Short-Term Investments	101.18	115.59	86.31	116.68	189.58	143.66
Cash Growth	31.03%	33.91%	-26.02%	-38.45%	31.96%	59.98%
Accounts Receivable	4	-	0.23	0.9	0.72	0.49
Other Receivables	-	-	1.47	11.9	-	-
Total Trade Receivables	4	-	1.7	12.8	0.72	0.49
Other Current Assets	3.51	3.16	6.98	6.88	8.81	17.6
Total Current Assets	108.69	118.74	94.99	136.36	199.11	161.75
Net Property, Plant & Equipment	6.65	7.23	10.18	8.26	13.78	29.33
Other Intangible Assets	1.13	1.17	0.62	0.4	0.73	2.05
Long-Term Investments	0.74	0.74	7.81	8.2	11.98	13.72
Other Long-Term Assets	26.68	26.54	22.79	6.56	12.57	4.64
Total Assets	143.89	154.42	136.39	159.78	238.17	211.5

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	0.94	0.3	1.31	2.97	0.65	1.14
Accrued Expenses	4.4	6.46	7.2	6.54	6.93	10.79
Current Portion of Long-Term Debt	-	-	-	22.41	-	-
Current Portion of Leases	1.56	1.51	1.32	1.13	1.68	1.82
Unearned Revenue	-	-	2.96	12.04	46.19	21.24
Other Current Liabilities	0.86	0.65	2.19	4.9	4.21	0.98
Total Current Liabilities	7.76	8.91	14.98	49.99	59.66	35.98
Long-Term Debt	22.42	22.4	22.32	-	22.22	2.48
Long-Term Leases	4.49	4.9	6.4	7.72	1.06	4.81
Other Long-Term Liabilities	33.13	25.95	36.29	83.21	94.79	77.06
Total Long-Term Liabilities	60.04	53.26	65.02	90.93	118.07	84.35
Total Liabilities	67.79	62.17	80	140.92	177.74	120.33

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0	0	0	0	0	-
Treasury Stock	-0.95	-0.95	-0.95	-0.95	-0.95	-0.95
Additional Paid-in Capital	623.68	621.39	539.81	509.44	489.7	408.8
Retained Earnings	-546.63	-528.19	-482.46	-489.63	-428.31	-316.68
Shareholders' Equity	76.1	92.25	56.39	18.86	60.43	91.17
Total Liabilities & Equity	143.89	154.42	136.39	159.78	238.17	211.5

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	28.47	28.81	30.05	31.27	24.96	9.11
Net Cash (Debt)	72.72	86.78	56.27	85.41	164.62	134.55
Net Cash Growth	53.17%	54.22%	-34.12%	-48.12%	22.35%	69.72%
Net Cash Per Share	4.36	6.77	8.17	22.23	56.19	68.78
Book Value	76.1	92.25	56.39	18.86	60.43	91.17
Book Value Per Share	4.57	7.19	8.19	4.91	20.63	46.60
Tangible Book Value	74.97	91.08	55.77	18.46	59.7	89.12
Tangible Book Value Per Share	4.50	7.10	8.10	4.81	20.38	45.56

SEC Filings: 10-K · 10-Q

Data Source: Fiscal.ai Last updated: May 5, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 24, 2026

Data Sources Report a data error